Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Belgium’s Ablynx submits marketing authorisation application for caplacizumab approval

pharmaceutical-technologyFebruary 08, 2017

Tag: caplacizumab , application

PharmaSources Customer Service